Aqua Medical
Lloyd Mencinger is an accomplished executive with extensive experience in the medical device and healthcare sectors. Currently serving as President & CEO of Aqua Medical Inc. since January 2017, Mencinger leads initiatives utilizing innovative vapor-based ablation technology aimed at treating type 2 diabetes and preventing esophageal and pancreatic cancers. Previous roles include Principal Advisor at Larta Institute, Vice President International at DFINE, and Vice President Sales & Marketing at EndoStim. Mencinger has also held notable positions within Tenet Healthcare as Senior Vice President of Business Development & Marketing, and within Boston Scientific across various executive capacities, including Vice President of Global Business Development & Strategy. Educational qualifications include an MBA from USC Marshall School of Business and a B.S. in Chemical Engineering from California State University, Long Beach, both with Cum Laude honors, alongside additional studies at Harvard Business School and The University of Chicago Booth School of Business.
This person is not in any teams
This person is not in any offices
Aqua Medical
Aqua Medical developed a vapor-based, endoscopic, ablation technology to treat gastrointestinal disease and prevent GI cancers. The company's ablation technology is consists of high-temperature water vapor created by a radiofrequency generator that delivers endoscopically through proprietary catheters to the GI tract.Aqua Medical was foundedin 2016 by Virender K. Sharma and is based in Santa Ana, California, United States.